<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.34711.004</object-id><label>Table 1.</label><caption><title>The effect of alkyl ester and tetrahydrobenzothiophene ring substitutions on the potency and efficacy of <bold>EU1794</bold> analogues.</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4"><inline-graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-34711-inf1-v1"/></th><th colspan="4">EC<sub>50</sub> (&#181;M) [conf. int.]* <break/>Maximal Degree of Modulation (% of control)<sup>&#8224;</sup></th></tr><tr><th>Compound</th><th>R<sub>1</sub></th><th>R1 volume (&#8491;<sup>3</sup>)</th><th>R<sub>2</sub></th><th>GluN2A</th><th>GluN2B</th><th>GluN2C</th><th>GluN2D</th></tr></thead><tbody><tr><td><bold>EU1794-4</bold></td><td>Et</td><td>45.15</td><td>H</td><td>2.2 [1.8, 2.8] <break/>32 &#177; 3%</td><td>2.6 [1.4, 4.8] <break/>67 &#177; 4%</td><td>0.42 [0.28, 0.61] <break/>52 &#177; 2%</td><td>0.36 [0.29, 0.45] <break/>51 &#177; 3%</td></tr><tr><td><bold>EU1794-2</bold></td><td>Et</td><td>45.15</td><td>Me</td><td>0.60 [0.44, 0.82] <break/>6 &#177; 2%</td><td>1.2 [0.8, 1.9] <break/>10 &#177; 3%</td><td>0.26 [0.21, 0.31] <break/>14 &#177; 1%</td><td>0.20 [0.17, 0.25] <break/>14 &#177; 1%</td></tr><tr><td><bold>EU1794-5</bold></td><td>iPr</td><td>62.16</td><td>H</td><td>18 [9.0, 36] <break/>36 &#177; 5%</td><td>2.5 [1.4, 4.4] <break/>71 &#177; 4%</td><td>4.0 [3.5, 4.6] <break/>140 &#177; 3%</td><td>9.3 [8.1, 11] <break/>169 &#177; 7%</td></tr><tr><td><bold>EU1794-19</bold></td><td>iPr</td><td>62.16</td><td>Me</td><td>1.1 [0.5, 2.3] <break/>19 &#177; 6%</td><td>1.1 [0.9, 1.3] <break/>43 &#177; 2%</td><td>0.74 [0.57, 0.96] <break/>32 &#177; 3%</td><td>0.43 [0.32, 0.59] <break/>46 &#177; 2%</td></tr><tr><td><bold>EU1794-27</bold></td><td>tBu</td><td>79.23</td><td>H</td><td>7.4 [5.3, 10] <break/>52 &#177; 7%</td><td>1.4 [1.2, 1.7] <break/>130 &#177; 3%</td><td>2.8 [2.5, 3.2] <break/>230 &#177; 10%</td><td>2.4 [1.8, 3.3] <break/>250 &#177; 8%</td></tr><tr><td><bold>EU1794-25</bold></td><td>Bn</td><td>98.87</td><td>H</td><td>-</td><td>1.0 [0.9, 1.2] <break/>220 &#177; 13%</td><td>0.77 [0.56, 1.0] <break/>180 &#177; 12%</td><td>1.0 [0.95, 1.1] <break/>250 &#177; 19%</td></tr><tr><td><bold>EU1794-29</bold></td><td>n-Bu</td><td>79.12</td><td>H</td><td>3.7 [1.7, 8.0] <break/>59 &#177; 5%</td><td>1.4 [1.1, 1.8] <break/>140 &#177; 3%</td><td>3.8 [2.6, 5.7] <break/>130 &#177; 7%</td><td>5.7 [5.1, 6.4] <break/>166 &#177; 8%</td></tr></tbody></table><table-wrap-foot><fn><p>*EC<sub>50</sub> values for potentiation of responses to saturating glutamate and glycine (100 &#956;M, 30 &#956;M) were obtained by least-squares fitting of data from individual experiments by the Hill equation. EC<sub>50</sub> values are given as the mean with the 95% confidence interval determined from log(EC<sub>50</sub>).</p><p><sup>&#8224;</sup>The maximal degree of modulation is given as mean&#160;&#177;SEM. For all compounds, data are from 4 to 18 oocytes recorded in at least two independent experiments. Data were not fit (shown as -) if the response recorded at 30 &#181;M of test compound did not differ by more than 15% from control.</p></fn></table-wrap-foot></table-wrap>